COMPANY PROFILE / #3250
Arctoris
Abingdon, United KingdomVenture Capital-Backed
OVERVIEW
Operator of an automated drug discovery platform intended to streamline the development of new drugs towards the clinic. The company leverages robotics and artificial intelligence to generate superior quality drug discovery data from a wide range of biochemical, cell-based and molecular biology assays conducted by robotics, enabling clients to make rapid decisions based on reliable, structured and well-annotated data, leading to faster and more efficient drug discovery programs.
已融资16.43
最新估值48.95
员工数42
成立年份2016
公司概况
- Companies
- Arctoris
- Description
- Operator of an automated drug discovery platform intended to streamline the development of new drugs towards the clinic. The company leverages robotics and artificial intelligence to generate superior quality drug discovery data from a wide range of biochemical, cell-based and molecular biology assays conducted by robotics, enabling clients to make rapid decisions based on reliable, structured and well-annotated data, leading to faster and more efficient drug discovery programs.
- Website
- www.arctoris.com
- HQ Location
- Abingdon, United Kingdom
- Year Founded
- 2016
- Keywords
- ai-powered drug discovery, automated experimentation, biotech discovery, biotech therapeutics, drug discovery project, experiment design, laboratory automation service
- Competitors
- Partek, Exscientia, Dnastar, Illumina, Strateos, Benchling, Affymetrix, Evotec, SnapGene, Emerald Cloud Lab
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 16.43
- First Financing Date
- 01-Nov-2017
- First Financing Size
- 0.18
- First Financing Valuation
- —
- Last Financing Date
- 14-Aug-2023
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 4.97
- Last Financing Valuation
- 48.95
- Last Financing Status
- Completed
- Last Known Valuation
- 48.95
- Last Known Valuation Date
- 14-Aug-2023
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 53.26
- Valuation Estimate Growth Rate
- 8.80%
- Active Investors
- Acequia Capital, Alexander Straub, Charles Songhurst, Creative Destruction Lab, Eurostars, Formic Ventures, Future Planet Capital, GK Goh Holdings, Innovate UK, Patrick Pichette, Tanarra Capital, TD Veen, UK Innovation Agency, Vishal Gulati
- # Active Investors
- 14
- Acquirers
- —
团队与联系人
- Employees
- 42
- Employee Growth %
- 2.44% E
- Employee History
- 2026: 42, 2025: 41 E, 2024: 39, 2023: 34, 2022: 29, 2021: 30
- Primary Contact
- Thomas Fleming
- Primary Contact Title
- Co-Founder, Board Member & Chief Executive Officer
- Primary Contact Email
- thomas.fleming@arctoris.com
- Primary Contact Phone
- +44 (0)77 1382 8576
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -0.27%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 9
- Size Multiple
- 8.64x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 91
- Majestic Referring Domains
- 313
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3250 · 所有字段均按数据库原值展示。